Daniel Billen, Director at Aurinia Pharmaceuticals Inc. (AUPH), sold 5,252 shares at $5.74 ($30K) on 2024-05-21, disclosed to the SEC on 2024-05-22.
Open-market sale of $30k AUPH by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.